Skip to Main Content

Paper Details

Clinical characteristics and outcomes after 5 years pro re nata treatment of neovascular age-related macular degeneration with ranibizumab.
Acta Ophthalmol
8
2015
Author NameAffiliation
Richard GaleYork Teaching Hospitals NHS Foundation Trust
  • 1 - 1

Datasets

Release 1.2